133 related articles for article (PubMed ID: 34811886)
1. A risk factor analysis for local recurrence of bone and soft tissue sarcoma treated with carbon ion radiotherapy: A retrospective cohort study at a single institution.
Kohama I; Yanagawa T; Okamoto M; Ohno T; Chikuda H
Asia Pac J Clin Oncol; 2022 Aug; 18(4):434-440. PubMed ID: 34811886
[TBL] [Abstract][Full Text] [Related]
2. Monitoring bone and soft-tissue tumors after carbon-ion radiotherapy using ¹⁸F-FDG positron emission tomography: a retrospective cohort study.
Yanagawa T; Saito K; Kiyohara H; Ohno T; Nakano T; Takagishi K
Radiat Oncol; 2015 Dec; 10():259. PubMed ID: 26691334
[TBL] [Abstract][Full Text] [Related]
3. Outcome and Toxicity of Carbon Ion Radiotherapy for Axial Bone and Soft Tissue Sarcomas.
Cuccia F; Fiore MR; Barcellini A; Iannalfi A; Vischioni B; Ronchi S; Bonora M; Riva G; Vai A; Facoetti A; Preda L; Valvo F; Vitolo V
Anticancer Res; 2020 May; 40(5):2853-2859. PubMed ID: 32366434
[TBL] [Abstract][Full Text] [Related]
4. [(11)C]methionine positron emission tomography and survival in patients with bone and soft tissue sarcomas treated by carbon ion radiotherapy.
Zhang H; Yoshikawa K; Tamura K; Tomemori T; Sagou K; Tian M; Kandatsu S; Kamada T; Tsuji H; Suhara T; Suzuki K; Tanada S; Tsujii H
Clin Cancer Res; 2004 Mar; 10(5):1764-72. PubMed ID: 15014030
[TBL] [Abstract][Full Text] [Related]
5. Impact of carbon ion radiotherapy for primary spinal sarcoma.
Matsumoto K; Imai R; Kamada T; Maruyama K; Tsuji H; Tsujii H; Shioyama Y; Honda H; Isu K;
Cancer; 2013 Oct; 119(19):3496-503. PubMed ID: 23939877
[TBL] [Abstract][Full Text] [Related]
6. Does an Algorithmic Approach to Using Brachytherapy and External Beam Radiation Result in Good Function, Local Control Rates, and Low Morbidity in Patients With Extremity Soft Tissue Sarcoma?
Klein J; Ghasem A; Huntley S; Donaldson N; Keisch M; Conway S
Clin Orthop Relat Res; 2018 Mar; 476(3):634-644. PubMed ID: 29443850
[TBL] [Abstract][Full Text] [Related]
7. Carbon ion radiotherapy for unresectable localized axial soft tissue sarcoma.
Imai R; Kamada T; Araki N;
Cancer Med; 2018 Sep; 7(9):4308-4314. PubMed ID: 30030906
[TBL] [Abstract][Full Text] [Related]
8. Carbon ion radiotherapy for unresectable retroperitoneal sarcomas.
Serizawa I; Kagei K; Kamada T; Imai R; Sugahara S; Okada T; Tsuji H; Ito H; Tsujii H
Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):1105-10. PubMed ID: 19467578
[TBL] [Abstract][Full Text] [Related]
9. [Management of soft tissue sarcomas in first isolated local recurrence: a retrospective study of 83 cases].
Moureau-Zabotto L; Thomas L; Bui BN; Chevreau C; Stockle E; Martel P; Bonneviale P; Marques B; Coindre JM; Kantor G; Matsuda T; Delannes M
Cancer Radiother; 2004 Oct; 8(5):279-87. PubMed ID: 15561593
[TBL] [Abstract][Full Text] [Related]
10. Fast neutron radiotherapy for soft tissue and cartilaginous sarcomas at high risk for local recurrence.
Schwartz DL; Einck J; Bellon J; Laramore GE
Int J Radiat Oncol Biol Phys; 2001 Jun; 50(2):449-56. PubMed ID: 11380233
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of carbon ion radiotherapy in bone and soft tissue sarcomas.
Kamada T; Tsujii H; Tsuji H; Yanagi T; Mizoe JE; Miyamoto T; Kato H; Yamada S; Morita S; Yoshikawa K; Kandatsu S; Tateishi A;
J Clin Oncol; 2002 Nov; 20(22):4466-71. PubMed ID: 12431970
[TBL] [Abstract][Full Text] [Related]
12. Carbon-ion Radiotherapy for Inoperable Head and Neck Bone and Soft-tissue Sarcoma: Prospective Observational Study.
Musha A; Kubo N; Kawamura H; Okano N; Sato H; Okada K; Osu N; Yumisaki H; Adachi A; Takayasu Y; Shino M; Nikkuni O; Ida S; Shirai K; Saitoh JI; Yokoo S; Chikamatsu K; Ohno T
Anticancer Res; 2022 Mar; 42(3):1439-1446. PubMed ID: 35220237
[TBL] [Abstract][Full Text] [Related]
13. Effectiveness of Carbon Ion Radiotherapy for Bone and Soft Tissue Sarcoma in Older Patients.
Kinoshita H; Yonemoto T; Yamada S; Imai R
Anticancer Res; 2024 Apr; 44(4):1773-1780. PubMed ID: 38537982
[TBL] [Abstract][Full Text] [Related]
14. Complication rate, functional outcomes, and risk factors associated with carbon ion radiotherapy for patients with unresectable pelvic bone sarcoma.
Takenaka S; Araki N; Outani H; Hamada KI; Yoshikawa H; Kamada T; Imai R
Cancer; 2020 Sep; 126(18):4188-4196. PubMed ID: 32658315
[TBL] [Abstract][Full Text] [Related]
15. Clinical Outcomes of Intensity-modulated Carbon-ion Radiotherapy for Bone and Soft Tissue Tumors.
Takakusagi Y; Koge H; Kano K; Shima S; Tsuchida K; Mizoguchi N; Yoshida D; Kamada T; Katoh H
Anticancer Res; 2023 Jun; 43(6):2777-2781. PubMed ID: 37247930
[TBL] [Abstract][Full Text] [Related]
16. Local recurrence of soft tissue sarcoma. A Scandinavian Sarcoma Group Project.
Trovik CS;
Acta Orthop Scand Suppl; 2001 Feb; 72(300):1-31. PubMed ID: 11381580
[TBL] [Abstract][Full Text] [Related]
17. Local surgery feasibility and safety after carbon ion radiotherapy for primary bone sarcomas.
Sabe H; Outani H; Imura Y; Takami H; Nakai T; Takenaka S; Kakunaga S; Tamiya H; Wakamatsu T; Nakai S; Demizu Y; Imai R; Okada S
J Orthop Sci; 2024 May; 29(3):903-907. PubMed ID: 37045686
[TBL] [Abstract][Full Text] [Related]
18. Soft tissue sarcomas.
Alvegård T
Acta Oncol; 1996; 35 Suppl 7():117-22. PubMed ID: 9154103
[TBL] [Abstract][Full Text] [Related]
19. Carbon ion radiotherapy for recurrent calf myxoid liposarcoma: a case report.
Li X; Zhang Y; Ye Y; Qi Y; Feng C; Zhang Y; Hu T; Chen W; Pan X; Chai H
J Int Med Res; 2021 Apr; 49(4):3000605211009701. PubMed ID: 33884917
[TBL] [Abstract][Full Text] [Related]
20. Usefulness of
Hasebe M; Yoshikawa K; Nishii R; Kawaguchi K; Kamada T; Hamada Y
Int J Oral Maxillofac Surg; 2017 Oct; 46(10):1220-1228. PubMed ID: 28535963
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
